-
Something wrong with this record ?
Účast EDRF-NO v regulacích kostního průtoku krve u potkanů: inhibice s L-NAME [The role of EDRF-NO in the regulation of bone blood flow in rats: inhibition with L-NAME]
J. Kapitola, J. Andrle, T. Haas, J. Kubícková,
Language Czech Country Czech Republic
Document type English Abstract, Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Femur blood supply MeSH
- Hemodynamics drug effects MeSH
- Bone and Bones blood supply MeSH
- Rats MeSH
- Methylene Blue pharmacology MeSH
- NG-Nitroarginine Methyl Ester pharmacology MeSH
- Ovariectomy MeSH
- Nitric Oxide antagonists & inhibitors biosynthesis physiology MeSH
- Strontium Radioisotopes MeSH
- Regional Blood Flow drug effects MeSH
- Blood Flow Velocity drug effects MeSH
- Tibia blood supply MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Female MeSH
- Animals MeSH
- Publication type
- English Abstract MeSH
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
EDRF-NO probably participates-besides the prostaglandins [3, 4]-in local circulatory changes in the bones of female rats with modified level of sex hormones; we could demonstrate it indirectly using methylene blue as a blocking agent [5]. In this paper, we present corresponding results of two experiments with NG-nitro-arginine methyl ester (L-NAME) as a substance blocking the production of endothelium derived relaxing factor, i.e. nitric oxide (EDRF-NO). Circulatory values were estimated by means of 85Sr-microspheres. In experiment A we ascertained whether the duration of L-NAME administration (0.025% in the food) influenced the effect. It could be demonstrated that the effect of one week's, two weeks', or four weeks' administration of L-NAME was the same: 85Sr-microsphere uptake and blood flow throught the tibia of female rats, increased after oophorectomy (OOX, performed four weeks prior to the experiment), was significantly suppressed to the level in sham-operated animals. In the experiment B, L-NAME was administered in the food in concentration of 0.05% for two weeks prior to the experiment. 85Sr-microsphere uptake was decreased significantly after L-NAME in the tibia of sham-operated females, in the tibia and distal femur of OOX animals; no significant changes were found in the diaphysis of femur and in calvaria. Blood flow values were significantly decreased in all bone samples of OOX females and in tibia of sham-operated rats (besides the local reaction also due to the decrease in the cardiac output). In both experiments the cardiac output was decreased and blood pressure elevated after L-NAME. It can be concluded, from the results of both experiments, that the blockade of EDRF-NO production by L-NAME decreases local circulatory values in the bones of female rats-particularly OOX-in a similar way as methylene blue; however, in contrast to methylene blue, L-NAME induces marked increase in the blood pressure and partially decrease in the cardiac output. Thus, as in the case of methylene blue, the effect of L-NAME on the circulation of blood in the rat bones supports the hypothesis of the participation of EDRF-NO in bone blood flow regulations.
Laborator pro endokrinologii a metabolismus lékarské fakulty Univerzity Karlovy Praha Czech Republic
The role of EDRF-NO in the regulation of bone blood flow in rats: inhibition with L-NAME
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18027804
- 003
- CZ-PrNML
- 005
- 20180809102134.0
- 007
- ta
- 008
- 180809s1996 xr f 000 0|cze||
- 009
- AR
- 035 __
- $a (PubMed)9424710
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a cze
- 044 __
- $a xr
- 100 1_
- $a Kapitola, J $u Laborator pro endokrinologii a metabolismus, lékarské fakulty Univerzity Karlovy, Praha, Czech Republic.
- 245 10
- $a Účast EDRF-NO v regulacích kostního průtoku krve u potkanů: inhibice s L-NAME / $c J. Kapitola, J. Andrle, T. Haas, J. Kubícková,
- 246 31
- $a The role of EDRF-NO in the regulation of bone blood flow in rats: inhibition with L-NAME
- 520 9_
- $a EDRF-NO probably participates-besides the prostaglandins [3, 4]-in local circulatory changes in the bones of female rats with modified level of sex hormones; we could demonstrate it indirectly using methylene blue as a blocking agent [5]. In this paper, we present corresponding results of two experiments with NG-nitro-arginine methyl ester (L-NAME) as a substance blocking the production of endothelium derived relaxing factor, i.e. nitric oxide (EDRF-NO). Circulatory values were estimated by means of 85Sr-microspheres. In experiment A we ascertained whether the duration of L-NAME administration (0.025% in the food) influenced the effect. It could be demonstrated that the effect of one week's, two weeks', or four weeks' administration of L-NAME was the same: 85Sr-microsphere uptake and blood flow throught the tibia of female rats, increased after oophorectomy (OOX, performed four weeks prior to the experiment), was significantly suppressed to the level in sham-operated animals. In the experiment B, L-NAME was administered in the food in concentration of 0.05% for two weeks prior to the experiment. 85Sr-microsphere uptake was decreased significantly after L-NAME in the tibia of sham-operated females, in the tibia and distal femur of OOX animals; no significant changes were found in the diaphysis of femur and in calvaria. Blood flow values were significantly decreased in all bone samples of OOX females and in tibia of sham-operated rats (besides the local reaction also due to the decrease in the cardiac output). In both experiments the cardiac output was decreased and blood pressure elevated after L-NAME. It can be concluded, from the results of both experiments, that the blockade of EDRF-NO production by L-NAME decreases local circulatory values in the bones of female rats-particularly OOX-in a similar way as methylene blue; however, in contrast to methylene blue, L-NAME induces marked increase in the blood pressure and partially decrease in the cardiac output. Thus, as in the case of methylene blue, the effect of L-NAME on the circulation of blood in the rat bones supports the hypothesis of the participation of EDRF-NO in bone blood flow regulations.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a rychlost toku krve $x účinky léků $7 D001783
- 650 _2
- $a kosti a kostní tkáň $x krevní zásobení $7 D001842
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a femur $x krevní zásobení $7 D005269
- 650 _2
- $a hemodynamika $x účinky léků $7 D006439
- 650 _2
- $a methylenová modř $x farmakologie $7 D008751
- 650 _2
- $a NG-nitroargininmethylester $x farmakologie $7 D019331
- 650 _2
- $a oxid dusnatý $x antagonisté a inhibitory $x biosyntéza $x fyziologie $7 D009569
- 650 _2
- $a ovarektomie $7 D010052
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a regionální krevní průtok $x účinky léků $7 D012039
- 650 _2
- $a radioizotopy stroncia $7 D013326
- 650 _2
- $a tibie $x krevní zásobení $7 D013977
- 655 _2
- $a anglický abstrakt $7 D004740
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Andrle, J
- 700 1_
- $a Haas, T
- 700 1_
- $a Kubícková, J
- 773 0_
- $w MED00011096 $t Sborník lékařský $x 0036-5327 $g Roč. 97, č. 4 (1996), s. 455-461
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/9424710 $y Pubmed
- 910 __
- $a ABA008 $b A 7 $c sign $y 4 $z 0
- 990 __
- $a 20180809 $b ABA008
- 991 __
- $a 20180809102458 $b ABA008
- 999 __
- $a ok $b bmc $g 1324633 $s 1024755
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 1996 $b 97 $c 4 $d 455-461 $i 0036-5327 $m Sborník lékařský (1910) $n Sb. lék. (1910) $x MED00011096
- LZP __
- $a Pubmed-20180809